ECA
AMGN icon

Elevated Capital Advisors’s Amgen AMGN Stock Holding History

Elevated Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$675K Sell
1,865
-1,095
-37% -$375K 0.19% 100
2026
Q1 		$1.04M Buy
2,960
+1,761
+147% +$628K 0.26% 93
2025
Q4 		$392K Sell
1,199
-208
-15% -$66K 0.09% 217
2025
Q3 		$397K Sell
1,407
-164
-10% -$47.6K 0.1% 218
2025
Q2 		$489K Hold
1,571
– – 0.14% 192
2025
Q1 		$489K Sell
1,571
-93
-6% -$27.5K 0.14% 192
2024
Q4 		$434K Buy
1,664
+125
+8% +$37.1K 0.12% 205
2024
Q3 		$496K Buy
1,539
+38
+3% +$12.4K 0.13% 202
2024
Q2 		$469K Buy
1,501
+173
+13% +$50.8K 0.13% 179
2024
Q1 		$378K Buy
1,328
+98
+8% +$28.7K 0.11% 148
2023
Q4 		$354K Buy
1,230
+114
+10% +$31.1K 0.11% 148
2023
Q3 		$300K Sell
1,116
-20
-2% -$4.99K 0.1% 151
2023
Q2 		$252K Buy
1,136
+134
+13% +$31.1K 0.08% 166
2023
Q1 		$242K Buy
1,002
+56
+6% +$13.7K 0.09% 160
2022
Q4 		$248K Buy
+946
New +$254K 0.09% 146
2019
Q4 		$251K Buy
+1,041
New +$229K 0.28% 98
2019
Q1 		$576K Buy
+2,598
New +$496K 0.38% 95

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Elevated Capital Advisors's AMGN Position: Q2 2026 in Review

Elevated Capital Advisors reduced its Amgen (AMGN) stake by 37% in Q2 2026, selling an estimated $375K and leaving 1,865 shares worth $675K. The position accounts for 0.19% of the portfolio, ranked #100.

Elevated Capital Advisors first reported a position in AMGN in Q1 2019 and has held it in 17 quarters since. The position peaked at $1.04M in Q1 2026. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Elevated Capital Advisors held 1,865 shares of Amgen worth $675K as of Q2 2026.
  • Elevated Capital Advisors sold 1,095 Amgen shares in Q2 2026, an estimated $375K.
  • Amgen made up 0.19% of Elevated Capital Advisors's portfolio in Q2 2026, its #100 holding.
  • Elevated Capital Advisors first reported a position in Amgen in Q1 2019 and has held it in 17 quarters since.
  • Elevated Capital Advisors's Amgen position peaked at $1.04M in Q1 2026.
  • 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.